Status
Conditions
Treatments
About
The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.
Full description
After being informed about the study and giving written informed consent, all eligible participants will be randomised into the experimental group or the control group (TAU). Participants will be blind to the group allocation.
The experimental group will undergo a two weeks OCD prevention program, consisting of three group sessions per week.
The control group will not receive any intervention.
Researchers will compare the experimental group to the control group to test wether the prevention programme is efficient in reducing OCD symptomatology.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Central trial contact
Roxana Cardoș, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal